UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

August 31, 2021

Date of Report (Date of Earliest Event Reported)

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

1007 Market Street

Wilmington, Delaware, 19801

(Address of principal executive offices)

Registrant’s telephone number, including area code: (302) 773-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 31, 2021, The Chemours Company (“Chemours”) board of directors voted to appoint Sandra Phillips Rogers to the Chemours board of directors, which was announced on September 1, 2021. The appointment, which is effective October 1, 2021, increases the size of the board of directors to ten members, eight of which have been determined by the board of directors to be independent under the listing standards of the New York Stock Exchange and Chemours’ Corporate Governance Guidelines.

Sandra Phillips Rogers, 55, currently serves as group vice president, chief legal officer, general counsel and corporate secretary of Toyota Motor North America (TMNA). In January of 2019, Ms. Rogers also took on the role of chief diversity officer (CDO) and oversight responsibility for Social Innovation, Sustainability and Regulatory Affairs and Compliance and Audit Office. Previously, Ms. Rogers was vice president and deputy general counsel, Toyota Motor Sales (TMS), U.S.A., Inc. and prior to joining Toyota in June 2012, Ms. Rogers was a partner at Morgan, Lewis & Bockius. She also previously served as senior vice president, associate general counsel and chief litigation counsel at Pfizer Inc., and was managing partner of the Houston office of Shook, Hardy & Bacon.

There are no arrangements or understandings between Ms. Rogers and any other persons in connection with her appointment. Ms. Rogers does not have any family relationships with any executive officer or director of Chemours and she is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Ms. Rogers has not yet been appointed to any committees of the board of directors.

Ms. Rogers will receive compensation as a non-employee director in accordance with the non-employee director compensation practices described in Chemours’ Annual Proxy Statement filed with the Securities and Exchange Commission on March 12, 2021.  Chemours and Ms. Rogers will also enter into Chemours’ standard form of indemnification agreement filed as Exhibit 10.28 to Chemours’ Annual Report on Form 10-K for the year ended December 31, 2015, filed with the Securities and Exchange Commission on February 25, 2016.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.